InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by MANUSO JAMES S J, Director. Officer active across 1 company, notably Ocuphire Pharma, Inc.. In total, 3 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €22k. Activity tracked since 18 November 2021. The latest transaction was filed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
5,000 shares@ US$1.9943.2% of flowCommon StockSEC:0001140361-22-020364:0
Ideal exit: 14 Feb 2023 (T+270)
2,000 shares@ US$3.50100.0% of flowCommon StockSEC:0001140361-21-038872
Ideal exit: 15 Aug 2022 (T+270)
2,000 shares@ US$3.5028.4% of flowCommon StockSEC:0001140361-21-038872:0
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About MANUSO JAMES S J
James S J Manuso is a Director at Ocuphire Pharma, Inc. He contributes to the governance of the company by bringing his expertise in strategy and business development. James is involved in key decisions that influence the future of Ocuphire Pharma.
